Everything else you wanted to know
Stem cell therapy is the use of stem cells to treat or prevent a disease or condition. Stem cell treatments are a type of cell therapy that introduces new cells into bodies for possible treatment of cancer, diabetes, and a host of other autoimmune diseases.
At Solutions for a Healthier World Foundation Inc., we raise funds to provide stem cell treatments for people who need them but cannot afford the cost of the stem cell treatments.
There are two things to consider about the use of stem cell therapies in the US and potential host countries outside the US. First, the existing legal structure surrounding research; second, the regulatory framework regarding application of that research to patients.
We associate with scientific teams that adhere to the US Food and Drug Administration (FDA) guidelines under the US Department of Health and Human Services, Code of Federal Regulation, part 1271 entitled “Regulation of Human Cells, tissues and Cellular and Tissue-based products.”
In it, the FDA distinguishes minimally manipulated cells and autologous transplantation from other cell types by stating “you are not required to comply with the requirements of this part if you are an establishment that removes human cells, tissues and cellular and tissue-based products from an individual and implants such products into the same individual during the same surgical procedure.” This implies that minimally manipulated and autologous cell therapy shouldn’t have regulations that are in place for other human cells, tissues, tissue-based products and drugs.
Adult HSC (hematopoietic stem cell) transplants under practice and approved by the FDA over the last 30 years including several malignant and non-malignant diseases. In our host countries, prohibitions are generally in place regulating the use of embryonic stem cells. For the most part, the science teams we associate with do not conduct research or treatments with embryonic stem cells.
For more info, click here
The stem cells used for treating a patient can be autologous, meaning they come from the person’s own body. They can also come from a family member or a donor. The scientists we associate with typically use autologous stem cells; however, there may be rare instances where donor cells are used. The scientific teams we work with typically do not use embryonic stem cells.
Regenerative stem cell therapy is proving to be the future of medical treatment for many degenerative diseases and injuries. Stem cells have the remarkable potential to develop into any cell type in the body. Their unique differentiation and unlimited multiplication properties make them important in the application of regenerative medicines.
Stem cells serve as the body’s primary internal repair system and can divide to replenish other cells. With the help of technical advancements, these stem cells can be ntroduced into the injured area of the patient to produce more healthy cells. If there’s an injury, chronic disease or inflammation, a stem cell has the potential to differentiate into whatever cell type needed to fix the problem. When healthy cells are introduced into the injured area, they turn on and augment the body’s own repair mechanism.
Stem cell therapies are being used to treat several autoimmune and/or degenerative diseases and conditions including but not limited to:
- ALS/Amyotrophic Lateral Sclerosis (Lou Gehrig’s disease)
- Cerebral Palsy
- Chronic Pain Syndrome
- COPD (Chronic obstructive pulmonary disease)
- Crohn’s Disease
- Diabetes Type 1 and Type 2
- Liver Cirrhosis and liver disease
- Multiple Sclerosis
- Muscular Dystrophy
- Parkinson’s Disease
- Retinal Transplant
- Rheumatoid Arthritis
- Skin burns
- Spinal Cord Injury
- Spinal Muscular Atrophy
Stem cell treatments have proven to be very effective in treating autoimmune diseases. Treatments vary by patient and length. But there have been numerous clinical trials and treatments over 100 days, 1 year, two years, three years and more that indicate stem cell treatments have led to recovery and remission for patients suffering from a number of autoimmune diseases including ALS (Amyotrophic Lateral Sclerosis or Lou Gehrig’s Disease), Parkinson’s Disease, Multiple Sclerosis (MS), Alzheimer’s Disease, kidney diseases, myasthenia gravis, Muscular Dystrophy (MD), osteoporosis, scleroderma/systemic sclerosis, liver cirrhosis, arthritis, osteoarthritis, etc.
This treatment has a proven track record of alleviating the suffering of millions of people throughout the world.
These are the results from clinical trials conducted by GIOSTAR, the Global Institute of Stem Cell Therapy and Research, over a two-year period:
- Patients with Parkinson’s Disease experienced a 63% remission rate after transplants;
- Patients with ALS or Lou Gehrig’s Disease experienced a remission rate of 67%; and,
- Patients with Multiple Sclerosis (MS) experienced a 67% remission rate after transplants.
And that’s just a small sample of the success of stem cell transplants.
Yes, Solutions for a Healthier World Foundation, Inc. is an Internal Revenue Service (IRS) recognized 501(c)(3) public charity. Donations made to Solutions are tax deductible under section 170 of the Internal Revenue code. Bequests, transfers and gifts are tax deductible under different sections of the code.
Yes. We’ll send a receipt to the email address specified and you may retain it and/or print it out for your records. If you paid using a credit or debit card, it should also appear on your card statement.
We strive to maintain a low gap between the charitable donations we receive and the amount that goes towards administrative and/or operational costs and marketing. Our goal is to allocate eighty-five (85) percent of charitable proceeds to directly fund stem cell treatments for children and other patients with autoimmune diseases around the world.
The Foundation is governed by a Board of Directors including Eric Stoffers, Bioscience Americas CEO; Bill Deegan, Biosciences America Executive Vice President and Tim Kopatich, Bioscience Americas Executive Vice President serving as ex-officio members of the Board. You can read their bios on the Leadership page of our website here. This link is under the About tab in the top-level navigation bar.
Solutions for a Healthier World Foundation, Inc. was established in October, 2016 and assigned Employer Identification Number (EIN) 81-4192561. We received Internal Revenue Service (IRS) approval as a tax exempt 501(c)(3) public charity on Dec. 23, 2016.
Just as no two people are alike nor is their medical condition or treatment. Stem cell therapies are not a one-size-fits-all treatment. The cost of one stem cell treatment can vary from as little as $5,000 or be well into triple figures.
We provide help to patients on a global basis.
Our Foundation does not fund or conduct research; our primary goal is to fund stem cell treatments for patients who need but cannot afford the treatments. However, we associate with stem cell scientists around the world to make sure that our patients receive the most technologically advanced immunological treatments available.
There is a process and it starts by completing our pre-qualification for treatment form which can be found on our website, www.solutionsfound.org under “Apply for Treatment.”
What if I know someone who might be able to benefit from these stem cell treatment services and cannot afford them?
We recommend that you have them complete the above-referenced pre-qualification for treatment form on our website, www.solutionsfound.org, under “Apply for Treatment.
We are located at 2122 E. Highland Ave., Suite 265; Phoenix, AZ 85016.
Our general phone number is 1-844-474-3399.
Eric Stoffers serves as Chairman of the Board; Bill Deegan serves as the CEO and is also a Trustee; Lynn Behlendorf serves as Executive Director and Guillermo Salazar serves as Vice President of International Development. For more information on our leadership and other Trustees, please visit our Leadership page on our website here.